Effect of lupus anticoagulants on INR with different thromboplastins [2]

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 6, 2000, Pages 579-581

  Pui, J C ^a   Pollak, Eleanor S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUPUS ANTICOAGULANT; REAGENT; THROMBOPLASTIN;

ANTICOAGULATION; ARTIFACT REDUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LETTER; PRIORITY JOURNAL; PROTEIN DETERMINATION;

BLOOD COAGULATION TESTS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUPUS COAGULATION INHIBITOR; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; THROMBOPLASTIN;

EID: 0033825370     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200009000-00011     Document Type: Letter

References (5)

1. Control of oral anticoagulation in patients with the antiphospholipid syndrome: Influence on the lupus anticoagulant on international normalized ratio
2. Monitoring warfarin therapy in patients with lupus anticoagulants
3. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants
4. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome
5. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome